欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0896/001
药品名称Ospolot 20 mg/ml oral suspension
活性成分
    • sultiame 20.0 mg/ml
剂型Oral suspension
上市许可持有人Desitin Arzneimittel GmbH Weg beim Jäger 214 22335 Hamburg, Germany
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Germany (DE)
      Ospolot 20 mg/ml Suspension zum Einnehmen
许可日期2020/05/19
最近更新日期2020/05/19
药物ATC编码
    • N03AX03 sultiame
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    撤市原因:1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised.
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase